Search by Drug Name or NDC

    NDC 71403-0101-05 Minolira Extended Release 105 mg/1 Details

    Minolira Extended Release 105 mg/1

    Minolira Extended Release is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by EPI Health, Inc. The primary component is MINOCYCLINE HYDROCHLORIDE.

    Product Information

    NDC 71403-0101
    Product ID 71403-101_8b6ea2e8-8582-4eb0-a98f-a32b239fee2f
    Associated GPIs 04000040107560
    GCN Sequence Number 077552
    GCN Sequence Number Description minocycline HCl TAB BP 24H 105 MG ORAL
    HIC3 W1C
    HIC3 Description TETRACYCLINE ANTIBIOTICS
    GCN 43597
    HICL Sequence Number 004015
    HICL Sequence Number Description MINOCYCLINE HCL
    Brand/Generic Brand
    Proprietary Name Minolira Extended Release
    Proprietary Name Suffix n/a
    Non-Proprietary Name Minocycline Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 105
    Active Ingredient Units mg/1
    Substance Name MINOCYCLINE HYDROCHLORIDE
    Labeler Name EPI Health, Inc
    Pharmaceutical Class Tetracycline-class Drug [EPC], Tetracyclines [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA209269
    Listing Certified Through 2022-12-31

    Package

    NDC 71403-0101-05 (71403010105)

    NDC Package Code 71403-101-05
    Billing NDC 71403010105
    Package 1 BOTTLE in 1 CARTON (71403-101-05) / 5 TABLET in 1 BOTTLE
    Marketing Start Date 2019-03-15
    NDC Exclude Flag N
    Pricing Information N/A